Ching Chen Chiu
Corporate Officer/Principal presso BELITE BIO, INC
Profilo
Ching Chen Chiu is currently the Vice President of Clinical Operations at Belite Bio, Inc. Prior to this, Chiu worked as an Executive Director at EPS International Co. Ltd.
and as a Managing Director and Director at CMIC Asia-Pacific Pte Ltd.
Chiu received a graduate degree from the University of Warwick and an undergraduate degree from Taipei Medical University.
Posizioni attive di Ching Chen Chiu
Società | Posizione | Inizio |
---|---|---|
BELITE BIO, INC | Corporate Officer/Principal | 01/11/2021 |
Precedenti posizioni note di Ching Chen Chiu
Società | Posizione | Fine |
---|---|---|
CMIC Asia-Pacific Pte Ltd. | Chief Executive Officer | - |
EPS International Co. Ltd.
EPS International Co. Ltd. Miscellaneous Commercial ServicesCommercial Services EPS International Co. Ltd. a subsidiary of a public listed company EPS Co. Ltd in Tokyo, Japan, commences its business operations in April 2007. The company aims to provide a seamless clinical research and development platform through strategizing and synergizing its established research networks, valuable knowledge, know-how, resources and experiences in Asia region. The company manages large- and small-scale, global and local clinical trials covering from first-in-man to post marketing surveillance for new chemical entities, biologics and medical devices. | Director/Board Member | - |
Formazione di Ching Chen Chiu
University of Warwick | Graduate Degree |
Taipei Medical University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
BELITE BIO, INC | Health Technology |
Aziende private | 2 |
---|---|
EPS International Co. Ltd.
EPS International Co. Ltd. Miscellaneous Commercial ServicesCommercial Services EPS International Co. Ltd. a subsidiary of a public listed company EPS Co. Ltd in Tokyo, Japan, commences its business operations in April 2007. The company aims to provide a seamless clinical research and development platform through strategizing and synergizing its established research networks, valuable knowledge, know-how, resources and experiences in Asia region. The company manages large- and small-scale, global and local clinical trials covering from first-in-man to post marketing surveillance for new chemical entities, biologics and medical devices. | Commercial Services |
CMIC Asia-Pacific Pte Ltd. |
- Borsa valori
- Insiders
- Ching Chen Chiu